Roivant Sciences Ltd. (ROIV)
USD 9.51
(-5.04%)
USD 9.51
(-5.04%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 477.85 Million USD | 11.39% |
| 2023 | 428.99 Million USD | 57.43% |
| 2022 | 272.49 Million USD | 17.12% |
| 2021 | 232.66 Million USD | 114.26% |
| 2020 | 108.59 Million USD | -10.99% |
| 2019 | 121.99 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 436.88 Million USD | 6.76% |
| 2024 Q2 | 438.07 Million USD | -100.0% |
| 2024 FY | 477.85 Million USD | 11.39% |
| 2024 Q3 | 450.39 Million USD | 2.81% |
| 2024 Q4 | 477.85 Million USD | 6.1% |
| 2023 Q1 | 444.11 Million USD | 62.98% |
| 2023 Q2 | 430.15 Million USD | -3.14% |
| 2023 Q4 | 428.99 Million USD | -0.25% |
| 2023 Q3 | 430.04 Million USD | -0.02% |
| 2023 FY | 428.99 Million USD | 57.43% |
| 2022 Q2 | 265.09 Million USD | 5.36% |
| 2022 FY | 272.49 Million USD | 17.12% |
| 2022 Q4 | 272.49 Million USD | 2.39% |
| 2022 Q1 | 251.61 Million USD | 8.14% |
| 2022 Q3 | 266.13 Million USD | 0.39% |
| 2021 Q3 | 166.32 Million USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 232.66 Million USD | 39.89% |
| 2021 FY | 232.66 Million USD | 114.26% |
| 2020 Q4 | 108.59 Million USD | 0.0% |
| 2020 FY | 108.59 Million USD | -10.99% |
| 2019 FY | 121.99 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -570.939% |
| Alkermes plc | 287.73 Million USD | -66.078% |
| Agenus Inc. | 137.32 Million USD | -247.977% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 79.605% |
| Aptorum Group Limited | 3.05 Million USD | -15523.868% |
| Ardelyx, Inc. | 51.54 Million USD | -827.03% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -356.806% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1092.255% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -375.015% |
| ChromaDex Corporation | 2.57 Million USD | -18457.515% |
| Chimerix, Inc. | 125 Thousand USD | -382184.8% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -14654.876% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -1744.434% |
| CRISPR Therapeutics AG | 223 Million USD | -114.278% |
| Precision BioSciences, Inc. | 7.72 Million USD | -6087.44% |
| Dyadic International, Inc. | 88.87 Thousand USD | -537602.262% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -2171972.727% |
| Fortress Biotech, Inc. | 60.85 Million USD | -685.224% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -776952.166% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -12471.85% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -530120.585% |
| Incyte Corporation | 29.16 Million USD | -1538.626% |
| IO Biotech, Inc. | 1.83 Million USD | -25884.557% |
| Jaguar Health, Inc. | 30.99 Million USD | -1441.819% |
| Novavax, Inc. | 168.01 Million USD | -184.411% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -1975.379% |
| Opthea Limited | 200.53 Million USD | -138.29% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -8203.319% |
| ContextLogic Inc. | 6 Million USD | -7864.267% |
| MiMedx Group, Inc. | 48.09 Million USD | -893.484% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -2277.511% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1247859.05% |
| NextCure, Inc. | 5.94 Million USD | -7932.543% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -329455.862% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -2061.169% |
| PDS Biotechnology Corporation | 19.5 Million USD | -2349.767% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -313.8% |
| Pharming Group N.V. | 166.1 Million USD | -187.683% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -7591.228% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -1325.797% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -39523.217% |
| Acelyrin, Inc. | 1.19 Million USD | -39921.441% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -103781.739% |
| Summit Therapeutics Inc. | 103.29 Million USD | -362.635% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -12578.588% |
| Senti Biosciences, Inc. | 33.53 Million USD | -1324.82% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -9911.649% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1282.845% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -692.188% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -30336.688% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -1781.027% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -357.988% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -65180.874% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -4170.003% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -245.511% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -3455.741% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -3085.707% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -150.275% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -807.471% |
| Fortress Biotech, Inc. | 60.85 Million USD | -685.224% |
| Precigen, Inc. | 5.89 Million USD | -8006.124% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1038.078% |
| AlloVir, Inc. | 16.64 Million USD | -2770.351% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -626.7% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -390.813% |
| ImmuCell Corporation | 10.54 Million USD | -4433.525% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -42376.089% |
| Onconetix, Inc. | 118.85 Thousand USD | -401942.791% |
| PureTech Health plc | 18.25 Million USD | -2518.389% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -482582.828% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1485.612% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -1740.456% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1014.559% |
| Innoviva, Inc. | 446.23 Million USD | -7.086% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -57265.666% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -714782.413% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -130.884% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -571.184% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -14889.21% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -45936.224% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -2040.357% |
| Aptose Biosciences Inc. | 621 Thousand USD | -76849.436% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -47168.763% |
| Century Therapeutics, Inc. | 46.65 Million USD | -924.167% |
| Kura Oncology, Inc. | 9.33 Million USD | -5020.617% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -1689.723% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -346172.464% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -4991.7% |
| Autolus Therapeutics plc | 47.91 Million USD | -897.32% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -9640.236% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -6955.308% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -265.725% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -5795.817% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1278.219% |
| INmune Bio, Inc. | 397 Thousand USD | -120266.751% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -175.02% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -11686.516% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -325084.928% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -860.09% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -775.675% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -945.797% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -0.948% |
| Verastem, Inc. | 40.08 Million USD | -1092.077% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -10755.429% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -4652.894% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -7183.28% |
| Histogen Inc. | 4.38 Million USD | -10800.0% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -54078.685% |
| Organovo Holdings, Inc. | 888 Thousand USD | -53712.613% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -1492.853% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -11293.801% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -2429.008% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -531.25% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -513149.699% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -1744.505% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -178872.285% |
| Amarin Corporation plc | 8.73 Million USD | -5369.337% |
| Mesoblast Limited | 100.48 Million USD | -375.559% |
| Turnstone Biologics Corp. | 1.18 Million USD | -40089.739% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -510.063% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -438300.0% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -482.687% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -151.577% |
| Better Therapeutics, Inc. | 10.34 Million USD | -4517.859% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -1966.404% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -413.641% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -36885.759% |
| Gritstone bio, Inc. | 40.14 Million USD | -1090.355% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -26242.668% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -211.118% |
| Insmed Incorporated | 1.19 Billion USD | 59.957% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -7425.291% |
| OmniAb, Inc. | 22.07 Million USD | -2064.693% |
| Alector, Inc. | 30.45 Million USD | -1469.004% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -370.59% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -5838.312% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -12.016% |
| Aura Biosciences, Inc. | 16.87 Million USD | -2732.579% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -739.906% |
| Immunic, Inc. | 639 Thousand USD | -74681.847% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -1502.522% |
| Veracyte, Inc. | 7.52 Million USD | -6250.246% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 25.898% |
| FibroGen, Inc. | 89.69 Million USD | -432.745% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -10918.123% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -365057.455% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 90.645% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1291402.703% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -24034.141% |
| TG Therapeutics, Inc. | 100.11 Million USD | -377.293% |
| Galecto, Inc. | 66 Thousand USD | -723924.242% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -351264.706% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 70.727% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -7844.406% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -8754.104% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -26242.668% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -2128.079% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -1207.225% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -92328.627% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -956.362% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -1462.949% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -966.595% |
| Vaxxinity, Inc. | 13.26 Million USD | -3503.197% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 41.097% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -106314.165% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -5336.978% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 82.321% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -151120.253% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -10619.067% |
| Ainos, Inc. | 5.92 Million USD | -7969.771% |
| Pluri Inc. | 29.05 Million USD | -1544.773% |
| Prothena Corporation plc | 10.72 Million USD | -4357.196% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -2307.214% |
| Celularity Inc. | 26.17 Million USD | -1725.48% |
| Rallybio Corporation | 173 Thousand USD | -276117.341% |
| Cue Biopharma, Inc. | 4.2 Million USD | -11272.109% |
| MeiraGTx Holdings plc | 72.11 Million USD | -562.594% |
| Omeros Corporation | 329.7 Million USD | -44.934% |
| Humacyte, Inc. | 38.6 Million USD | -1137.969% |
| Immunocore Holdings plc | 82.64 Million USD | -478.21% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -29525.294% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -13259.128% |
| Blueprint Medicines Corporation | 610.96 Million USD | 21.786% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -32674.76% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -402.008% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -881.546% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -425.688% |
| Pulmatrix, Inc. | 8.32 Million USD | -5638.633% |
| Elicio Therapeutics, Inc. | 6 Million USD | -7854.986% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -3591.433% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -393.923% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -101788.273% |
| Cytokinetics, Incorporated | 607.37 Million USD | 21.324% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -5397.653% |
| Nutriband Inc. | 79.82 Thousand USD | -598522.003% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -10556.913% |
| Vor Biopharma Inc. | 31.83 Million USD | -1401.276% |
| Evogene Ltd. | 10.65 Million USD | -4385.647% |
| ProKidney Corp. | 3.61 Million USD | -13137.008% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -62858.63% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -1815048.522% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 72.469% |
| CorMedix Inc. | 517.01 Thousand USD | -92326.303% |
| BioLineRx Ltd. | 6.62 Million USD | -7109.656% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -1197.182% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -566.085% |
| Atai Life Sciences N.V. | 15.21 Million USD | -3041.516% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -56626.287% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -187294.51% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1007.43% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -116262.928% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -34805.478% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -71964.051% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -168.353% |
| Biomea Fusion, Inc. | 7.83 Million USD | -6002.886% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -68.133% |
| Mereo BioPharma Group plc | 5.3 Million USD | -8916.151% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -22125.86% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -81168.027% |
| Absci Corporation | 4.66 Million USD | -10154.421% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -4047.336% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -2005.556% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -4676.172% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -4053.464% |
| Allakos Inc. | 38.21 Million USD | -1150.441% |
| Imunon, Inc. | 1.13 Million USD | -41843.205% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -5437.791% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -57059.809% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -4778460.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -440.891% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -10047.717% |
| XOMA Corporation | 118.51 Million USD | -303.193% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -4645.814% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -1188.751% |
| aTyr Pharma, Inc. | 13.76 Million USD | -3371.025% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -5949.576% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -1814.18% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -2265.038% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -3185606.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -171673.248% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -3205.851% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 68.127% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -350818.317% |
| UroGen Pharma Ltd. | 98.55 Million USD | -384.882% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -220.464% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -2406.194% |
| Entera Bio Ltd. | 256 Thousand USD | -186562.5% |
| GH Research PLC | 631 Thousand USD | -75629.952% |
| Lisata Therapeutics, Inc. | 137.00 USD | -348799900.0% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -74332.399% |
| Xencor, Inc. | 14.64 Million USD | -3163.598% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -317938.482% |
| Replimune Group, Inc. | 71.99 Million USD | -563.781% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -318470.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -6720.668% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -350818.317% |
| Portage Biotech Inc. | 7000.00 USD | -6826414.286% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -71964.051% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -33339.888% |
| OncoCyte Corporation | 2.2 Million USD | -21581.307% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -714130.626% |
| Purple Biotech Ltd. | 163 Thousand USD | -293063.19% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -18750.335% |
| scPharmaceuticals Inc. | 38.81 Million USD | -1131.239% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -1792.949% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -654497.26% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -25688.235% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -1713.633% |
| Curis, Inc. | 1.48 Million USD | -31992.411% |
| Daré Bioscience, Inc. | 3.91 Million USD | -12109.902% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -68388.71% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -7964166.667% |
| BeiGene, Ltd. | 197.61 Million USD | -141.808% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -52325.233% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -493.057% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -820.92% |
| bluebird bio, Inc. | 224.41 Million USD | -112.93% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 19.43% |
| DBV Technologies S.A. | 4.52 Million USD | -10458.02% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -35560.896% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -4805.112% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -12585.32% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -26.664% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1014.481% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -27730.868% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -51393.103% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -2635.765% |
| MacroGenics, Inc. | 30.19 Million USD | -1482.514% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -2599.294% |
| Prime Medicine, Inc. | 4.35 Million USD | -10867.546% |
| Aditxt, Inc. | 1.04 Million USD | -45770.771% |
| Adagene Inc. | 13.54 Million USD | -3429.208% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -3378.605% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 7.876% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -2695.624% |
| SciSparc Ltd. | 24 Thousand USD | -1990966.667% |
| Vericel Corporation | 81.85 Million USD | -483.776% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -482.632% |
| Generation Bio Co. | 89.77 Million USD | -432.288% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -2053.96% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -136.798% |
| Invivyd, Inc. | 722 Thousand USD | -66085.042% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -885.229% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -16343953.657% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -12392.967% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -2077534.783% |
| 2seventy bio, Inc. | 244.01 Million USD | -95.832% |
| ADMA Biologics, Inc. | 130.59 Million USD | -265.91% |
| Clene Inc. | 7.15 Million USD | -6581.432% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -14053.417% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -92.982% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -43301.998% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -181687.61% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -148.082% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -1582.414% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -4857.527% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -327.906% |
| Evaxion Biotech A/S | 8.48 Million USD | -5529.286% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -537.779% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -638.401% |
| Trevena, Inc. | 35.23 Million USD | -1256.274% |
| Surrozen, Inc. | 882 Thousand USD | -54078.685% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -7587.516% |
| Cingulate Inc. | 135.09 Thousand USD | -353608.022% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -1930.061% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -899.699% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -265375.556% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -1782.88% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -2640.471% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -50952.991% |
| Statera Biopharma, Inc. | 11.43 Million USD | -4080.3% |
| ImmunityBio, Inc. | 836.95 Million USD | 42.905% |
| Korro Bio, Inc. | 31.21 Million USD | -1430.805% |
| Kineta, Inc. | 150 Thousand USD | -318470.667% |
| BioVie Inc. | 349.89 Thousand USD | -136471.647% |
| Codexis, Inc. | 12.24 Million USD | -3803.096% |
| Celularity Inc. | 26.17 Million USD | -1725.48% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -904.849% |
| Celcuity Inc. | 37.03 Million USD | -1190.268% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -270877.913% |
| Cibus, Inc. | 17.67 Million USD | -2603.723% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -14041.935% |
| Kodiak Sciences Inc. | 100 Million USD | -377.856% |
| Annexon, Inc. | 29.19 Million USD | -1537.054% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -639.406% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -42489.661% |
| Avalo Therapeutics, Inc. | 2 Million USD | -23792.8% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 65.877% |
| Eyenovia, Inc. | 8.95 Million USD | -5234.863% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -627.784% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -5769.025% |
| Arcellx, Inc. | 50.84 Million USD | -839.903% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -32674.76% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -2150.005% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -45194.408% |
| Moolec Science SA | 99.04 Thousand USD | -482358.656% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -1630.046% |
| Geron Corporation | 35.05 Million USD | -1263.316% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -80755.499% |
| Royalty Pharma plc | 6.13 Billion USD | 92.211% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -29002.071% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1505337.591% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -1964.351% |
| Humacyte, Inc. | 38.6 Million USD | -1137.969% |
| Structure Therapeutics Inc. | 4.01 Million USD | -11807.7% |
| 89bio, Inc. | 24.79 Million USD | -1827.227% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -3743.14% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -25508.574% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -46203.876% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -380.219% |
| Notable Labs, Ltd. | 1.52 Million USD | -31214.286% |
| Liquidia Corporation | 2.36 Million USD | -20113.875% |
| Mustang Bio, Inc. | 1.97 Million USD | -24058.544% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -3378.605% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -6772.659% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -150643.218% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -858.069% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -4875.594% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -729573.686% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -351264.706% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -7528.608% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -367481.538% |
| PepGen Inc. | 17.1 Million USD | -2694.48% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -100713.502% |
| United Therapeutics Corporation | 300 Million USD | -59.285% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -1895.973% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -11379.053% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -82574.048% |
| XOMA Corporation | 118.51 Million USD | -303.193% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1291402.703% |
| Bionomics Limited | 117.62 Million USD | -306.243% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -51117.149% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -8417.932% |
| uniQure N.V. | 130.06 Million USD | -267.398% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -715.593% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -69558.309% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -10918.123% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -34402.238% |
| Altimmune, Inc. | 175 Thousand USD | -272960.571% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -23.204% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -8417.932% |
| Compugen Ltd. | 719 Thousand USD | -66361.196% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -9332.61% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -465.142% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -4712.246% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -7391.08% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -422.761% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -4712.246% |
| Instil Bio, Inc. | 81.42 Million USD | -486.852% |
| argenx SE | 15.35 Million USD | -3012.257% |
| Immunome, Inc. | 1.34 Million USD | -35560.896% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -89052.239% |
| Verona Pharma plc | 48.37 Million USD | -887.836% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -5085.069% |
| Shattuck Labs, Inc. | 3.4 Million USD | -13929.83% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -562083.529% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -284338.095% |
| Moolec Science SA | 99.04 Thousand USD | -482358.656% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -4231.519% |
| AnaptysBio, Inc. | 16.03 Million USD | -2879.709% |
| Design Therapeutics, Inc. | 2.33 Million USD | -20373.693% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -1765095.227% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -7864.267% |
| Achilles Therapeutics plc | 1.07 Million USD | -44310.409% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -5085.069% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -2396850.241% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -2754.161% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -598522.003% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -6404617.866% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -3675715.385% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -39.527% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -1851.707% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -19014.316% |
| Palisade Bio, Inc. | 90 Thousand USD | -530851.111% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -246217.526% |
| Beam Therapeutics Inc. | 159.91 Million USD | -198.826% |
| Neurogene Inc. | 13.37 Million USD | -3473.289% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -55.948% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -1719.503% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -798696.429% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -47685.6% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1079.658% |
| Athira Pharma, Inc. | 1.21 Million USD | -39165.078% |
| Vaccinex, Inc. | 26 Thousand USD | -1837807.692% |
| HCW Biologics Inc. | 6.3 Million USD | -7479.821% |
| XOMA Corporation | 118.51 Million USD | -303.193% |
| Nektar Therapeutics | 112.62 Million USD | -324.289% |
| Arvinas, Inc. | 800 Thousand USD | -59632.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -3205.851% |
| Merus N.V. | 10.48 Million USD | -4456.217% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -3110.319% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -3458.389% |
| Rezolute, Inc. | 1.66 Million USD | -28686.506% |
| Clene Inc. | 7.15 Million USD | -6581.432% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -651391.52% |
| BeyondSpring Inc. | 3.36 Million USD | -14104.994% |
| Synlogic, Inc. | 12.49 Million USD | -3725.602% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -1363.302% |
| Krystal Biotech, Inc. | 6.62 Million USD | -7118.369% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -179.58% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -7869.58% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1008652.19% |
| MannKind Corporation | 252.15 Million USD | -89.512% |
| Ikena Oncology, Inc. | 7.18 Million USD | -6555.376% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -240028.643% |
| Gossamer Bio, Inc. | 197.4 Million USD | -142.069% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -91795.385% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -69.857% |
| Mural Oncology plc | 8.91 Million USD | -5262.541% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -992.592% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -33176.88% |
| Champions Oncology, Inc. | 6.09 Million USD | -7742.705% |
| REGENXBIO Inc. | 82.22 Million USD | -481.178% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -96631.396% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -10677.086% |
| Vaxart, Inc. | 2.62 Million USD | -18117.918% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -175821.01% |
| Cellectis S.A. | 36.24 Million USD | -1218.551% |
| Longeveron Inc. | 1.44 Million USD | -32901.105% |
| Repare Therapeutics Inc. | 1.01 Million USD | -47212.475% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 57.806% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -967.381% |
| Revolution Medicines, Inc. | 80.57 Million USD | -493.057% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -14795.761% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -269875.141% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -388400.813% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 34.062% |
| Denali Therapeutics Inc. | 44.98 Million USD | -962.351% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -3721.549% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -353608.022% |
| Passage Bio, Inc. | 22.92 Million USD | -1984.796% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -7812.833% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -73757.187% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -2269.73% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -97421.633% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -117177.651% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -40123.569% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -102444.206% |
| OmniAb, Inc. | 22.07 Million USD | -2064.693% |
| Anew Medical, Inc. | 1.54 Million USD | -30929.61% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -1516.564% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -5190.114% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -1437.009% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -11686.516% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -826.85% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -7405.199% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -3282.094% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -71009.524% |
| Alumis Inc. Common Stock | 30.86 Million USD | -1448.464% |
| Equillium, Inc. | 384 Thousand USD | -124341.667% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -7658.662% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -216.358% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -877.63% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -397113.679% |
| Dominari Holdings Inc. | 3.02 Million USD | -15681.242% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -2416609.655% |
| vTv Therapeutics Inc. | 169 Thousand USD | -282655.03% |
| Bio-Techne Corporation | 319 Million USD | -49.798% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -738.52% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -167.607% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -3001.551% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -3758.968% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -9840.836% |
| Nkarta, Inc. | 82.27 Million USD | -480.839% |
| BioCardia, Inc. | 982 Thousand USD | -48561.507% |
| Iterum Therapeutics plc | 18.95 Million USD | -2420.869% |